Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Meditation may tame migraines: new study tests transcendental technique

NCT ID NCT06695156

Symptom relief Sponsor: Maharishi International University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 2 times

Summary

This pilot study is testing whether the Transcendental Meditation technique can reduce how often migraines happen and how much they interfere with daily life. Thirty adults with migraines will practice meditation twice a day for 20 minutes over three months while continuing their usual care. Researchers will track changes in migraine frequency, disability, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Transcendental Meditation technique
What this could lead to
If it works, this could offer a drug-free way to ease migraine symptoms and improve daily functioning.
What could go wrong
This is a very small, early pilot study with no control group, so results may not be reliable or generalizable. The meditation requires a significant time commitment (40 minutes daily).

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Aug 2024

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: * Diagnosis of migraine with or without aura, based on ICHD3 criteria * 4 and above migraine days/month. * · Episodic (4-14) vs chronic migraine (15+) * ≥ one-year history of migraines starting before the age of 50. * ≥ 18 years old or ≤ 60 Years old * Willing to attend follow-up sessions. * Willing to practice TM twice a day for 20 minutes. * Fluent in English. Willing to continue the same medication without any additional medicine In good general health, with no other diseases expected to interfere with the study. Exclusion criteria: * \> 60 years old or \< 18 Years old * Already practicing Transcendental Meditation. * Pre-diagnosed major systemic illness or unstable medical/psychiatric condition (eg, suicide risk) requiring immediate treatment or that could compromise protocol adherence * Medication overuse headache (MOH) * Current/planned pregnancy or breastfeeding * New prophylactic migraine medicine started within 4 weeks of the screening visit * Unwilling to maintain stable migraine medication dosages * Failure to complete baseline headache logs.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Migraine are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

migraine disorder migraine without aura

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Migraine Migraine, with or without aura

Contacts and locations

Locations

  • Georgetown Headache Center and DC area

    Washington D.C., District of Columbia, 20036, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.